Atlas Trials

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

Clinical trial NCT06067984 · COMPLETED

Trial details

NCT number
NCT06067984
Sponsor
Click Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SchizophreniaNegative Symptoms in Schizophrenia
Start date
2023-09-12
Primary completion
2025-06-13
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.